Complete Genomics Raises IPO Target to $96.6M

In an amended S-1 form filed today, the company said it plans to offer 6 million shares of its stock at between $12 and $14 per share. It also reported preliminary earnings results for the quarter ended Sept. 30.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories